San Diego, CA, United States of America

Jeffrey A Encinas

This inventor holds 1 USPTO granted patent. Top assignee: Axikin Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey A Encinas. Retrieved from https://idiyas.com/inventor/jeffrey-a-encinas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey A. Encinas

Introduction

Jeffrey A. Encinas is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the regulation of kinase activity. His work focuses on therapeutic applications that can benefit patients suffering from chronic diseases.

Latest Patents

Encinas holds a patent for the "Regulation of kinase, regulated in COPD kinase (RC kinase)." This patent involves reagents that regulate human RC Kinase activity and bind to human RC Kinase gene products. The therapeutic implications of this invention are profound, as it can be utilized to treat chronic obstructive pulmonary disease, asthma, cancer, and other diseases characterized by defective cell signaling. He has 1 patent to his name.

Career Highlights

Currently, Encinas is associated with Axikin Pharmaceuticals, Inc., where he continues to innovate in the field of medical research. His work is pivotal in developing new treatments that can improve the quality of life for patients with chronic conditions.

Collaborations

Encinas has collaborated with esteemed colleagues such as Shinichi Watanabe and Shinichi Kondo. These partnerships enhance the research and development efforts at Axikin Pharmaceuticals, Inc.

Conclusion

Jeffrey A. Encinas exemplifies the spirit of innovation in biotechnology. His contributions to the regulation of kinase activity are paving the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…